Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03771820
Title Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors NanoCarrier Co., Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries POL | HUN | HRV | CZE

Facility Status City State Zip Country Details
0603 RECRUITING Osijek Croatia Details
0601 RECRUITING Zagreb Croatia Details
0602 RECRUITING Zagreb Croatia Details
0701 RECRUITING Brno Czechia Details
0702 RECRUITING Hradec Králové Czechia Details
0703 RECRUITING Olomouc Czechia Details
0104 RECRUITING Budapest Hungary Details
0105 RECRUITING Debrecen Hungary Details
0103 RECRUITING Kecskemét Hungary Details
0101 RECRUITING Pécs Hungary Details
0202 RECRUITING Bydgoszcz Poland Details
0201 RECRUITING Łódź Poland Details
0801 RECRUITING Ekaterinburg Russian Federation Details
0802 RECRUITING Omsk Russian Federation Details
0301 RECRUITING Belgrade Serbia Details
0303 RECRUITING Niš Serbia Details
0301 RECRUITING Sremska Kamenica Serbia Details
0404 RECRUITING Taichung City Taiwan Details
0402 RECRUITING Taipei city Taiwan Details
0403 RECRUITING Taipei city Taiwan Details
0401 RECRUITING Taoyuan City Taiwan Details
0902 RECRUITING Cherkasy Ukraine Details
0903 RECRUITING Ivano-Frankivs'k Ukraine Details
0904 RECRUITING Kharkiv Ukraine Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field